3 (<50) If #DOAC strongly preferred, favour rivaroxaban with paed/wt based dosaging, but off license in adults. antiXa activity #vte #anticoagulation #thrombosis https://t.co/7eQUFjMsSz
https://t.co/aC3L0g5gNB 韓国 低体重例へのDOAC使用の安全性について
RT @Manugrillo2: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight #AFib #ACOD https://t.co/…
RT @Manugrillo2: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight #AFib #ACOD https://t.co/…
RT @Manugrillo2: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight #AFib #ACOD https://t.co/…
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight #AFib #ACOD https://t.co/J2pQh6brfl
RT @Manugrillo2: Anticoagulantes orales directos en pacientes con fibrilación auricular no valvular y bajo peso corporal #DOACS #ACODs htt…
DOACは低体重(<50kg)患者においてもワルファリンより有効かつ安全かもしれない。 https://t.co/golMkWwWBL
DOACs in very low weight patients (< 50 kg) seems to be safe and better than warfarin according to new research. https://t.co/nJjd7FTebZ https://t.co/0BECS5wV9G
RT @ATRIUMRx: In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to…
RT @ATRIUMRx: In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to…
RT @ATRIUMRx: In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to…
RT @ATRIUMRx: In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to…
RT @ATRIUMRx: In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to…
RT @ATRIUMRx: In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to…
In a recent study conducted in Asians with NVAF and low body weight, DOACs had superior effectiveness and safety compared to warfarin, and regular dosing of DOACs had similar outcomes compared to reduced dosing. #CardioTwitter #FOAMed #CardioEd https://t
RT @DrDerekConnolly: Direct Oral Anticoagulants are safe in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight @AAU_Thrombo…
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
Direct Oral Anticoagulants are safe in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight @AAU_Thrombosis https://t.co/CZKLxrf82L
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
RT @JACCJournals: DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SN…
DOACs appear safe in very low body weight patients. Is it time to switch our practices? https://t.co/lw7bPdk1tT #JACC @SNUnow https://t.co/rd3cz70xXp
RT @LiverpoolCCS: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight https://t.co/LGXcjNCJEP
RT @LiverpoolCCS: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight https://t.co/LGXcjNCJEP
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
RT @JACCJournals: How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @Hos…
How do DOACs fare in a very low body weight Asian population? See the results: https://t.co/SYCI2ZEyj9 #JACC @SNUnow @HospitalSeoul https://t.co/LJAgjnC6p6
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight https://t.co/GHNUPhC6E0
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @JORARTU: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight | JACC: Journal of the America…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight | JACC: Journal of the American College of Cardiology https://t.co/D7zSE023I0
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @Manugrillo2: Anticoagulantes orales directos en pacientes con fibrilación auricular no valvular y bajo peso corporal #DOACS #ACODs htt…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
RT @gonzaeperez: DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #War…
DOACS EN PAC CON #Afib Y BAJO PESO Datos de la vida real. pts ≤60 kg peso. CHADsVASC 4 prom. 14000 pts #DOACs vs 7500 #Warfarina DOACs fue más efectivo y seguro que Warfarina, sin diferencias entre dosis optima y reducidas. Via @JACCJournals https://t.co
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @Manugrillo2: Anticoagulantes orales directos en pacientes con fibrilación auricular no valvular y bajo peso corporal #DOACS #ACODs htt…
RT @Manugrillo2: Anticoagulantes orales directos en pacientes con fibrilación auricular no valvular y bajo peso corporal #DOACS #ACODs htt…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @LiverpoolCCS: Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight https://t.co/LGXcjNCJEP
Anticoagulantes orales directos en pacientes con fibrilación auricular no valvular y bajo peso corporal #DOACS #ACODs https://t.co/qFwdBac7yy
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
RT @JTLLERGO: DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better…
DOAC in Patients With NVAF and Low Body Weight (LBW): 🇰🇷 2014-2016 years registry 1️⃣ in <60 kg patients, DOACs showed better effectiveness and safety than warfarin 2️⃣ These results were consistent in patients with extremely LBW (<50 kg) @secardiolo
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight https://t.co/LGXcjNCJEP